Ultrasomics in liver cancer: Developing a radiomics model for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma using contrast-enhanced ultrasound

doi:10.4329/wjr.v16.i7.247

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1066)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

HTML

531

Figures (1-3)

Tables (1-3)

Sum=689

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=192

Publishing Process of This Article

Item

Count

Browse

Download

116

Sum=155

Jul 28, 2024 (publication date) through Sep 26, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Radiology

ISSN

1949-8470

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Radiol. Jul 28, 2024; 16(7): 247-255
Published online Jul 28, 2024. doi: 10.4329/wjr.v16.i7.247

Full Size Figure Download Figure

Figure 2 Image acquisition illustration. A and D: Baseline ultrasound (US) images of two target lesions; B and E: Contrast-enhanced ultrasound (CEUS) images of the target lesions at peak enhancement of arterial phase; C and F: CEUS images of the target lesions at 120 s after injection of contrast agent.

Citation: Su LY, Xu M, Chen YL, Lin MX, Xie XY. Ultrasomics in liver cancer: Developing a radiomics model for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma using contrast-enhanced ultrasound. World J Radiol 2024; 16(7): 247-255
URL: https://www.wjgnet.com/1949-8470/full/v16/i7/247.htm
DOI: https://dx.doi.org/10.4329/wjr.v16.i7.247